For application-focused DNA methylation profiling using MethylScreen technology with laboratory-verified assays

  • Experimentally verified real-time PCR primers
  • Specifically for DNA methylation analysis
  • Simultaneously profile methylation of 22 or 94 genes
  • No bisulfite conversion required
  • Available for human, mouse, and rat samples
EpiTect Methyl II PCR Arrays allow the simultaneous DNA methylation of a panel of 22 or 94 gene promoters on 96- or 384-well real-time PCR plates. Genes are carefully selected based on their reported hypermethylation in a variety of experimental settings. These arrays allow correlation of CpG island methylation status with biological phenotypes or disease outcomes. Both EpiTect Methyl II Signature PCR Arrays and EpiTect Methyl II Complete PCR Arrays are available for human, mouse, or rat studies in 96- or 384-well format. EpiTect Methyl II PCR Arrays use MethylScreen technology provided under license from Orion Genomics, LLC.
Product Product no. Cat. no. List price:
 
 
Show details
    varies
Can't order online?
To place an order via phone, email or for requesting a quote, please provide the product’s name, number and catalog number.
Configure
Product Product no. Cat. no. List price:
 
 
Show details
    varies
Can't order online?
To place an order via phone, email or for requesting a quote, please provide the product’s name, number and catalog number.

EpiTect Methyl II PCR Arrays are intended for molecular biology applications. These products are not intended for the diagnosis, prevention, or treatment of a disease.


  • Main Image Navi
EpiTect Methyl II PCR Assay detects methylation in heterogeneous samples.|Comparison with bisulfite Sanger sequencing.|EpiTect Methyl II PCR Array procedure.|EpiTect Methyl II PCR Arrays verify breast cancer gene methylation status in breast cancer cell lines.|EpiTect Methyl II PCR Arrays discover new candidate breast cancer DNA methylation biomarkers.|EpiTect Methyl II PCR Arrays generate data comparable to that from BeadChip platforms.|Pictorial explanation of EpiTect Methyl II PCR Assay results.|
Analytical sensitivity was tested using a serial dilution of SKBR3 genomic DNA and peripheral blood leukocyte genomic DNA. Using Human HIC1 DNA EpiTect Methyl II PCR Primers, the percentage of methylated HIC1 relative to the total amount of input DNA was detectable even down to only 6% of the total DNA sample. The HIC1 gene promoter is methylated in cancer cells and unmethylated in normal cells.|Methylation levels in the CDH13 promoter region were analyzed using EpiTect Methyl II PCR Assays or bisulfite Sanger sequencing. EpiTect Methyl II PCR Assays were performed using the EpiTect Methyl II PCR Assay Handbook protocol. For bisulfite sequencing, genomic DNA was bisulfite converted and amplified with gene-specific methylation-independent primers that included the amplicon region designed for the EpiTect Methyl II PCR Assay. PCR products were purified and sub-cloned; 16 colonies for each gene in each cell line were sequenced.|The system relies on the differential cleavage of target sequences by two different restriction endonucleases. qPCR allows the analysis of the methylation status of up to 94 targets simultaneously. SEC and DEC are control assays for monitoring enzymatic activities of restriction digestion enzymes.|The heat map compares the methylation status of genes in the genomic DNA of 3 breast cancer cell lines and blood genomic DNA (control), as determined by the Human Breast Cancer Signature Panel EpiTect Methyl II PCR Arrays.|This heat map compares the methylation status of a panel of 79 transcription factor genes in 6 different breast cancer cell lines (some in duplicate) and a normal epithelial cell line as determined using 384-well EpiTect Methyl II Custom PCR Arrays. These results are consistent with the concept that aberrant expression of transcription factors controlling cell differentiation plays a key role in oncogenesis and that transcription factors can be tumor suppressors, and may provide a new source of cancer biomarkers.
|EpiTect Methyl II PCR Array and Illumina Infinium Human Methylation 27 BeadChip assays were performed on MCF-7 cells. A representative analysis of 22 genes is shown. For better comparison, results from the EpiTect Methyl II PCR Array were converted to averaged beta values, in which 0 means completely unmethylated and 1 means completely methylated.
|EpiTect Methyl II PCR Assays and Arrays provide gene methylation status as percentage unmethylated (UM) and percentage methylated (M) fraction of input DNA. In these examples, the horizontal bar represents the targeted region of a gene from one genome. Biological samples usually contain many genomes derived from many cell types; here, five such genomes are depicted. Light and dark circles represent unmethylated and methylated CpG sites, respectively. In example 2, the targeted region of a gene has two or more methylated CpG sites in two out of five genomes. Thus, the EpiTect Methyl II PCR Assay data reveal that this gene is 60% unmethylated and 40% methylated.
|
Performance
EpiTect Methyl II PCR Arrays have been used to successfully verify the methylation status of tumor suppressor genes in breast cancer cell lines (see figure "Verification of breast cancer gene methylation status"). EpiTect Methyl II PCR Arrays provide high sensitivity (see figure "EpiTect Methyl II PCR Assay detects methylation in heterogeneous samples"). Results are comparable to methylation analysis using bisulfite sequencing (see figure "Comparison with bisulfite Sanger sequencing") and can provide verification for genome-wide methylation analysis studies (see figure "EpiTect Methyl II PCR Arrays generate data comparable to that from BeadChip platforms"). EpiTect Methyl II Custom PCR Arrays are also highly suited for discovery of DNA methylation biomarkers (see figure "EpiTect Methyl II PCR Arrays discover new candidate breast cancer DNA methylation biomarkers").
Principle

DNA methylation plays an important role in gene expression and it occurs almost exclusively in the context of CpG dinucleotides in the form of a covalent attachment of a methyl residue to the cytosine residue. CpG islands are regions with an elevated GC content and a high frequency of CpG dinculeotides which overlap with the promoter region of 60–70% of all human genes. Hypermethylation of CpG islands at gene promoters is mostly associated with gene silencing.

The EpiTect Methyl II PCR Array system, using MethylScreen technology, relies on the differential cleavage of target sequences by two different restriction endonucleases whose activities require either the presence or absence of methylated cytosines in their respective recognition sequences. As real-time PCR quantifies the relative amount of DNA remaining after each enzyme digestion (see flowchart "EpiTect Methyl II PCR Array procedure"), the methylation status of individual genes and the methylation profile across a gene panel are reliably and easily calculated (see figure "Pictorial explanation of results"). The use and analysis of both restriction digests, as well as their PCR amplification, allow the analysis of smaller, more heterogeneous samples.

The EpiTect Methyl II PCR System is an innovative technology enabling fast and accurate detection of DNA methylation status of individual genes, as well as disease- or pathway-related gene panels, without bisulfite conversion of DNA. The results of the Epitect Methyl II PCR System can then be verified using PyroMark CpG Assays. The performance of the EpiTect Methyl II PCR Arrays is guaranteed when used with the appropriate RT2 SYBR® Green qPCR Mastermix.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Array layout and format
Layout

The PCR Arrays are available in both 96- and 384-well plate formats to analyze the methylation status of 22 or 94 genes related to a disease state, such as specific types of cancer, or development pathways related to specific cells or tissues. Custom panels are also available. The signature panels of 22 genes are arranged on either 96-well or 384-well plates to simultaneously characterize all 4 restriction digests from either one or 4 different DNA samples, respectively. The complete panels of 94 genes are arranged on 96- or 384-well plates to characterize one DNA sample either on 4 plates or all on the same plate, respectively. In addition to the 22 or 94 genes, each array contains 2 controls to monitor enzymatic digestion efficiency.

 

 

 

 

 

Array formats
EpiTect Methyl II PCR Array Format A: 96-well plates containing dried qPCR primer assays, Optical Thin-Wall 8-Cap Strips
EpiTect Methyl II PCR Array Format C: 96-well plates containing dried qPCR primer assays, Optical Adhesive Film
EpiTect Methyl II PCR Array Format D: 96-well plates containing dried qPCR primer assays, Optical Thin-Wall 8-Cap Strips
EpiTect Methyl II PCR Array Format E (Signature Panels): 384-well plate(s) containing dried qPCR primer assays, Optical Adhesive Film, 384EZLoad Covers
EpiTect Methyl II PCR Array Format E (Complete Panels): 384-well plate(s) containing dried qPCR primer assays, Optical Adhesive Film
EpiTect Methyl II PCR Array Format F: 96-well plates containing dried qPCR primer assays, Optical Adhesive Film
EpiTect Methyl II PCR Array Format G (Signature Panels): 384-well plate(s) containing dried qPCR primer assays, Optical Adhesive Film, 384EZLoad Covers
EpiTect Methyl II PCR Array Format G (Complete Panels): 384-well plate(s) containing dried qPCR primer assays, Optical Adhesive Film, Optical Adhesive Film
Cancer-focused arrays
Breast cancer
Cancer miRNA
Colon cancer
Epithelial-to-mesenchymal transition (EMT)
Gastric cancer
Leukemia and lymphoma
Liver cancer
Lung cancer
Melanoma
Prostate cancer
Tumor suppressor genes
Pathway-focused arrays
Apoptosis
Cell cycle
Cytokine production
DNA repair
Homeobox (HOX) genes
Inflammatory response and autoimmunity
Mental disorders
Notch signaling pathway
Polycomb & trithorax complexes
Stem cell transcription factors
Stress & toxicity
T cell and B cell activation
T helper cell differentiation
TGF-β/BMP signaling
Toll-like receptor signaling
Tumor suppressor genes
WNT signaling

 

 

 

 

 

 

 

 

 

 

Procedure

First, add equal amounts of each genomic DNA sample to components of the EpiTect Methyl II DNA Restriction Kit to set up 4 different restriction digests: mock (Mo), methyl-sensitive (Ms), methyl-dependent (Md), and double (Msd). After digestion and heat inactivation of the enzymes, mix each digest with the appropriate RT2 SYBR Green qPCR Mastermix, aliquot into the appropriate wells of the EpiTect Methyl II PCR Array, and run the recommended cycling program in your real-time PCR instrument.

Determine the CT values for the characterization of each digest with each gene-specific assay using your instrument’s software. Then, paste the values into the Excel-based data analysis template for the array format, in order to calculate the percentages of methylated and unmethylated DNA.

Applications

The EpiTect Methyl II PCR system is an innovative technology and versatile tool for:

Methylation pattern profiling
Validation of genomewide methylation analyses
Cancer and stem cell biomarker discovery
Toxicological and epidemiological screening
Characterization of gene expression regulation
Epigenetic DNA methylation analysis

You are not authorized to download the resource

Instrument Technical Documents
1
For pathway- or disease-focused profiling of regional DNA methylation, without bisulfite conversion, using MethylScreenTM technology
Show details